Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE TrialArvin K. George, Jonathan Coleman, Amit R. Patel et al.|European Urology|2025Cited by 15